1321. Population Pharmacokinetic (PK) and Pharmacokinetic/Pharmacodynamic (PK/PD) Target Attainment Analyses for Dalbavancin in Pediatric Patients

por Carrothers, Timothy J, Lagraauw, H Maxime, Lindbom, Lars, Riccobene, Todd
Publicado 2020

Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Target Attainment Analyses for Dalbavancin in Pediatric Patients

por Carrothers, Timothy J., Lagraauw, H. Maxime, Lindbom, Lars, Riccobene, Todd A.
Publicado 2022

Stress-induced mast cell activation contributes to atherosclerotic plaque destabilization

por Lagraauw, H. Maxime, Wezel, Anouk, van der Velden, Daniël, Kuiper, Johan, Bot, Ilze
Publicado 2019

Complement factor C5a induces atherosclerotic plaque disruptions

por Wezel, Anouk, de Vries, Margreet R, Lagraauw, H Maxime, Foks, Amanda C, Kuiper, Johan, Quax, Paul HA, Bot, Ilze
Publicado 2014

Mast cell depletion in the preclinical phase of collagen-induced arthritis reduces clinical outcome by lowering the inflammatory cytokine profile

por van der Velden, Daniël, Lagraauw, H. Maxime, Wezel, Anouk, Launay, Pierre, Kuiper, Johan, Huizinga, Tom W. J., Toes, René E. M., Bot, Ilze, Stoop, Jeroen N.
Publicado 2016